BioMimetic Therapeutics (BMTI +12.2%) soars a day after reporting positive data from a small trial testing its augment bone graft device in patients undergoing surgery for rotator cuff injuries. The FDA last month declined to approve the graft and sought more data, but the new information boosts hopes of attracting interest from potential partners.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs